Lumos Pharma | NLNK - Aktuelle Verpflichtungen



Aktuelle Verpflichtungen Veränderung Datum
Agenus USD 249.24M 74.25M 2026-03
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Capricor Therapeutics USD 33.64M 2.2M 2026-03
Celldex Therapeutics USD 51.47M 481K 2026-03
Cipla INR 70.14B 7.16B 2026-03
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.04M 533K 2026-03
CSL USD 4.61B 207M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Grifols EUR 2.37B 156.97M 2025-12
Incyte USD 1.31B 177.55M 2026-06
Intrexon USD 23.02M 38K 2024-06
Merck USD 26.94B 1.38B 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Pfizer USD 34.35B 2.64B 2026-03
Prothena USD 32.52M 8.33M 2026-03
Sarepta Therapeutics USD 499.16M 596.13M 2026-03